Is there a survival advantage of incomplete resection of non-small-cell lung cancer that is found to be unresectable at thoracotomy?

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 4, 2013, Pages 529-532

  Dall, Keltie ^a   Ford, Christopher ^a   Fisher, Rachael ^a   Dunning, Joel ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Debulking; Exploratory thoracotomy; Incomplete resection; Macroscopic residual; Microscopic residual; Non small cell lung; Review

Indexed keywords

ARTICLE; BRONCHOSCOPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONSERVATIVE TREATMENT; EVIDENCE BASED MEDICINE; HUMAN; INCOMPLETE RESECTION; INOPERABLE CANCER; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; MEDIASTINUM METASTASIS; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; THORACOTOMY;

BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PNEUMONECTOMY; SURVIVAL ANALYSIS; SURVIVAL RATE; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875130044     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs428     Document Type: Article

References (10)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2: 405-9.
2. Rami-Porta R, Mateu-Navarro M, Freixinet J, de la Torre M, Torres-García AJ, Pun YW et al. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Type of resection and prognosis in lung cancer. Experience of a multicentre study. Eur J Cardiothorac Surg 2005;28: 622-8.
3. Duque J, Lopez-Encuentra A, Porta R; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Survival of 2,991 patients with surgical lung cancer: the denominator effect in survival. Chest 2005;128: 2274-81.
4. Ichinose Y, Hara N, Ohta M, Yano T, Maeda K, Asoh H. Survival of patients with non-small cell lung cancer undergoing incomplete resection or exploratory thoracotomy with no resection. Lung Cancer 1993;8: 265-74.
5. Hara N, Ohta M, Tanaka K, Ichinose Y, Noge S, Miyazaki K et al. Assessment of the role of surgery for stage III bronchogenic carcinoma. J Surg Oncol 1984;25: 153-8.
6. Yang H, Hou X, Lin P, Rong T, Yang H, Fu J. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer. Ann Thorac Surg 2009;88: 372-8.
7. Downey R, Martini N, Rusch V, Bains M, Korst R, Ginsberg R. Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg 1999;68: 188-93.
8. Martini N, Yellin A, Ginsberg R, Bains M, Burt M, McCormack P et al. Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 1994;58: 1447-51.
9. Burt M, Pomerantz A, Bains M, McCormack P, Kaiser L, Hilaris B et al. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 1987;67: 987-1000.
10. Ratto G, Fabiano F, Rovida S, Baracco F, De Palma M. Survival after incomplete resection or exploratory thoracotomy in patients with advanced non small cell lung cancer. Ital J Surg Sci 1988;18: 377-83.